Final results of a phase II trial of trabectedin (T) in triple-negative, HER2-positive, and BRCA1/2 germ-line-mutated metastatic breast cancer (MBC) patients (pts).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 1125-1125 ◽  
Author(s):  
K. L. Tedesco ◽  
J. L. Blum ◽  
A. Goncalves ◽  
J. Lubinski ◽  
C. R. C. Osborne ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Triple Negative ◽  
Germ Line ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Her2 Positive

A phase II trial of trabectedin (T) in patients (pts) with HER2-positive and BRCA1/2 germ-line-mutated metastatic breast cancer (MBC).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 1038-1038 ◽  
Author(s):  
K. L. Tedesco ◽  
J. L. Blum ◽  
A. Goncalves ◽  
J. Lubinski ◽  
N. Ben-Baruch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Germ Line ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Her2 Positive

A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast Cancer

2010 ◽  
Vol 28 (8) ◽  
pp. 865-871 ◽  
Author(s):  
Denise A. Yardley ◽  
Davey Daniel ◽  
Michael Stipanov ◽  
D. Randolph Drosick ◽  
Mark Mainwaring ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Her2 Positive
Sign in / Sign up

Export Citation Format

Share Document